To direct the Chairman of the Joint Chiefs of Staff to conduct a feasibility study on incorporating militarily-relevant applications of emerging biotechnology into wargaming exercises, and for other purposes.

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5193 Introduced in House (IH)]

<DOC>






119th CONGRESS
  1st Session
                                H. R. 5193

   To direct the Chairman of the Joint Chiefs of Staff to conduct a 
feasibility study on incorporating militarily-relevant applications of 
    emerging biotechnology into wargaming exercises, and for other 
                               purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           September 8, 2025

    Mr. Khanna (for himself, Mr. Garamendi, and Mr. Davis of North 
  Carolina) introduced the following bill; which was referred to the 
                      Committee on Armed Services

_______________________________________________________________________

                                 A BILL


 
   To direct the Chairman of the Joint Chiefs of Staff to conduct a 
feasibility study on incorporating militarily-relevant applications of 
    emerging biotechnology into wargaming exercises, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. FEASIBILITY STUDY ON INCORPORATING MILITARILY RELEVANT 
              APPLICATIONS OF EMERGING BIOTECHNOLOGY INTO WARGAMING 
              EXERCISES.

    (a) In General.--The Chairman of the Joint Chiefs of Staff shall 
conduct a review to determine the feasibility and advisability 
modifying the design of wargaming exercises to ensure that such 
exercises incorporate militarily relevant applications of emerging 
biotechnology.
    (b) Elements.--In conducting the review required under subsection 
(a), the Chairman of the Joint Chiefs of Staff shall take into 
account--
            (1) biotechnology-enabled enhancements that improve the 
        cognitive and physical performance of warfighters;
            (2) biotechnology-enabled chemicals and materials intended 
        to provide a strategic advantage on the battlefield;
            (3) adversaries' use of biotechnology for military purposes 
        beyond traditional biological weapons; and
            (4) any other militarily relevant applications of 
        biotechnology determined appropriate by the Chairman.
    (c) Consultation.--In conducting the review under subsection (a), 
the Chairman of the Joint Chiefs of Staff shall consult with--
            (1) the commanders of the combatant commands; and
            (2) other stakeholders within and outside the Department of 
        Defense, as necessary, to identify recent militarily relevant 
        advancements in the field of biotechnology that could 
        potentially be incorporated into exercises.
    (d) Report.--Not later than 180 days after the date of the 
enactment of this Act, the Chairman of the Joint Chiefs of Staff shall 
submit to the Committees on Armed Services of the Senate and the House 
of Representatives a report on the results of the review conducted 
under subsection (a). The report shall include--
            (1) a detailed summary of any recommended modifications to 
        wargaming exercises; and
            (2) if applicable, a plan for regularly updating the design 
        of such exercises to keep pace with advances in biotechnology.
    (e) Wargaming Exercise Defined.--In this section, the term 
``wargaming exercise'' means a military exercise conducted to test or 
improve tactical expertise, and includes the Globally Integrated 
Wargames.
                                 <all>